SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.48+0.4%Dec 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (444)10/23/1999 11:05:00 PM
From: scaram(o)uche  Read Replies (2) of 1475
 
Wish I'd have gone back and checked the site again before tonight. I had gotten the impression that the same general stuff was all that would be posted.

The exact wording from the Novartis milestone release...... "The scientific milestone involved inducing organ tolerance in a large animal model following an improved
preparative treatment regimen. In this proof-of-concept demonstration, mixed chimerism and organ tolerance were
achieved-both of which are key components of the Company's xenotransplantation approach."

Still doesn't mean that it was pig to primate, but..... you can bet that I'm going to call the company and ask again on Tuesday.

- g -

Go Sachs! Go Sykes! Go BTRN!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News